D'Angelo G, Struman I, Martial J, Weiner R I
Reproductive Endocrinology Center, University of California School of Medicine, San Francisco 94143, USA.
Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6374-8. doi: 10.1073/pnas.92.14.6374.
A number of factors both stimulating and inhibiting angiogenesis have been described. In the current work, we demonstrate that the angiogenic factor vascular endothelial growth factor (VEGF) activates mitogen-activated protein kinase (MAPK) as has been previously shown for basic fibroblast growth factor. The antiagiogenic factor 16-kDa N-terminal fragment of human prolactin inhibits activation of MAPK distal to autophosphorylation of the putative VEGF receptor, Flk-1, and phospholipase C-gamma. These data show that activation and inhibition of MAPK may play a central role in the control of angiogenesis.
已描述了许多刺激和抑制血管生成的因素。在当前的研究中,我们证明血管生成因子血管内皮生长因子(VEGF)可激活丝裂原活化蛋白激酶(MAPK),正如先前对碱性成纤维细胞生长因子所显示的那样。人催乳素的抗血管生成因子16 kDa N端片段可抑制MAPK在假定的VEGF受体Flk-1和磷脂酶C-γ自磷酸化之后的激活。这些数据表明,MAPK的激活和抑制可能在血管生成的控制中起核心作用。